Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis

ClinicalTrials.gov ID: NCT04856891

Public ClinicalTrials.gov record NCT04856891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Patients With Moderately to Severely Active Eosinophilic Duodenitis Who Have an Inadequate Response With, Lost Response to, or Were Intolerant to Standard Therapies

Study identification

NCT ID
NCT04856891
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allakos Inc.
Industry
Enrollment
94 participants

Conditions and interventions

Interventions

  • AK002 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 19, 2021
Primary completion
Jun 13, 2022
Completion
Jan 8, 2023
Last update posted
Jan 1, 2024

2021 – 2023

United States locations

U.S. sites
39
U.S. states
17
U.S. cities
38
Facility City State ZIP Site status
Allakos Investigational Site Birmingham Alabama 35209
Allakos Investigational Site Gilbert Arizona 85234
Allakos Investigational Site Chula Vista California 91910
Allakos Investigational Site Lomita California 90717
Allakos Investigational Site Wheat Ridge Colorado 80033
Allakos Investigational Site Bristol Connecticut 06010
Allakos Investigational Site Hamden Connecticut 06518
Allakos Investigational Site Brandon Florida 33511
Allakos Investigational Site Edgewater Florida 32132
Allakos Investigational Site Jacksonville Florida 32256
Allakos Investigational Site Kissimmee Florida 34741
Allakos Investigational Site Lakewood Rch Florida 34211
Allakos Investigational Site New Port Richey Florida 34653
Allakos Investigational Site Ponte Vedra Florida 32081
Allakos Investigational Site Crowley Louisiana 70526
Allakos Investigational Site Reno Nevada 89511
Allakos Investigational Site Florham Park New Jersey 07932
Allakos Investigational Site Great Neck New York 11023
Allakos Investigational Site Concord North Carolina 28027
Allakos Investigational Site Durham North Carolina 27710
Allakos Investigational Site Cincinnati Ohio 45219
Allakos Investigational Site Cincinnati Ohio 45231
Allakos Investigational Site Dayton Ohio 45415
Allakos Investigational Site Mentor Ohio 44094
Allakos Investigational Site Greenwood South Carolina 29646
Allakos Investigational Site Chattanooga Tennessee 37421
Allakos Investigational Site Hermitage Tennessee 37076
Allakos Investigational Site Hixson Tennessee 37343
Allakos Investigational Site Austin Texas 78745
Allakos Investigational Site Cedar Park Texas 78613
Allakos Investigational Site Fort Worth Texas 76104
Allakos Investigational Site Lubbock Texas 79410
Allakos Investigational Site San Antonio Texas 78229
Allakos Investigational Site Southlake Texas 76092
Allakos Investigational Site Webster Texas 77598
Allakos Investigational Site Ogden Utah 84405
Allakos Investigational Site Salt Lake City Utah 84132
Allakos Investigational Site Sandy City Utah 84092
Allakos Investigational Site Fredericksburg Virginia 22401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04856891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 1, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04856891 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →